Randomized phase II study of neoadjuvant chemotherapy and trastuzumab for operable breast cancer with overexpression of HER2

Authors
Category Primary study
JournalJournal of Clinical Oncolog
Year 2009
This article has no abstract
Epistemonikos ID: 98c67cfec766d0a1ef2354f826814d1778adf79b
First added on: Oct 05, 2017